Cite
HARVARD Citation
Meany, H. et al. (n.d.). Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL. Journal of immunotherapy. 38 (7), p. . [Online].